Avita Medical | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Celltrion KRW 17.14T 298.25B 2025-03
Clinuvel Pharmaceuticals AUD 203.01M 24.36M 2024-06
Cochlear AUD 1.87B 27.1M 2024-12
CSL USD 20.55B 3.18B 2024-12
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Kangmei Pharma CNY 7.18B 8.52M 2025-03
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 581.54M 98.78M 2024-12
Malin Corporation EUR 193.2M 75M 2024-12
Mayne Pharma AUD 454.19M 93.58M 2024-06
Medical Developments International AUD 55.33M 9.6M 2024-12
Nanosonics AUD 189.03M 6.82M 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Pacific Edge NZD 40.66M 13.96M 2024-09
Paradigm Biopharmaceuticals AUD 34.06M 10.25M 2024-12
Pharma Mar EUR 197.47M 10.89M 2025-03
Polynovo AUD 72.12M 3.07M 2024-06
PYC Therapeutics AUD 55.44M 25.62M 2024-12
Qiagen NV USD 3.41B 159.46M 2025-03
Ramsay Health Care AUD 4.81B 82.9M 2024-12
ResMed USD 5.25B 57.98M 2024-12
Sartorius EUR 2.71B 1.19B 2025-03
Sino Biopharmaceutical CNY 31.96B 884.2M 2024-12
Telix Pharmaceuticals AUD 568.21M 164.24M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Zz Pientze Pharmaceu 15.26B 991.2M 2025-03



Avita Medical Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jun 2025.